Rubino said people taking existing obesity medications lose an average of about 7% to 9% of their body weight. “People who require 10%, 15%, 20% weight loss, we need tools,” she said.
” We need to think about weight problems no different than high blood pressure, than high cholesterol, than diabetes,” stated Dr. Domenica Rubino, the director of the Washington Center for Weight Management and Research. Rubino said individuals taking existing obesity medications lose approximately about 7% to 9% of their body weight. “People who require 10%, 15%, 20% weight loss, we require tools,” she stated.
Throughout a 16-month study, patients on Wegovy lost an average of 17% of their body weight. Side results included diarrhea and queasiness, which usually fixed as the dosage was slowly increased. Trial individual Lisa Robillard lost 63 pounds.
Wegovy is comparable to the diabetes drug Ozempic, which is already being recommended off-label for weight loss. Both drugs mimic a natural hormonal agent that assists regulate hunger.” These hormonal agents actually impact signals in the brain,” Rubino stated.
America has a brand-new weapon in the fight versus weight problems. The FDA on Friday authorized a new weight-loss drug, Wegovy, for people who are either obese or overweight and have at least one weight-related medical problem..
Wegovy is comparable to the diabetes drug Ozempic, which is currently being prescribed off-label for weight loss.